BD BBL™ MOTILITY INDOLE ORNITHINE (MIO) MEDIUM
Mexico·Clase I·III. DIAGNOSTIC AGENTS·BECTON DICKINSON DE MÉXICO, S.A. DE C.V.·Registered March 20, 2018PARA UTILIZARSE COMO INDICADOR DE MOVILIDAD, PRODUCCIÓN DE INDOL Y ACTIVIDAD DE ORNITINA DESCARBOXILASA PARA LA DIFERENCIACIÓN DE ENTEROBACTERIAS. PARA USO EXCLUSIVO EN LABORATORIOS CLÍNICOS O DE GABINETE. AGENTE DE DIAGNÓSTICO, USO IN VITRO
TO BE USED AS AN INDICATOR OF MOBILITY, INDOLE PRODUCTION AND ORNITHINE DECARBOXYLASE ACTIVITY FOR THE DIFFERENTIATION OF ENTEROBACTERIA. FOR USE IN CLINICAL OR CABINET LABORATORIES ONLY. DIAGNOSTIC AGENT, IN VITRO USE
- Risk Class / Clase de Riesgo
- Clase I
- Product Type (Spanish)
- III. AGENTES DE DIAGNÓSTICO
- Product Type (English)
- III. DIAGNOSTIC AGENTS
- Trade Name (Spanish)
- MEDIO DE CULTIVO PREPARADO EN TUBO
- Trade Name (English)
- CULTURE MEDIUM PREPARED IN TUBE
- Analysis ID
- 784R2018 SSA
- Registration Date
- March 20, 2018
- Name (Spanish)
- BECTON DICKINSON DE MÉXICO, S.A. DE C.V.
- Name (English)
- BECTON DICKINSON DE MÉXICO, S.A. DE C.V.
Access comprehensive regulatory information for BD BBL™ MOTILITY INDOLE ORNITHINE (MIO) MEDIUM (BD BBL™ MOTILITY INDOLE ORNITHINE (MIO) MEDIUM) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 784R2018 SSA and manufactured by BECTON DICKINSON DE MÉXICO, S.A. DE C.V.. The device was registered on March 20, 2018.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.